Lower-middle income (World Bank) vs Slovakia: Hypertension: effective treatment coverage (controlled hypertension)
Lower-middle income (World Bank)
13.9%
in 2019
Slovakia
36.1%
in 2019
Lower-middle income (World Bank) rank
12th
Slovakia rank
14th
Hypertension: effective treatment coverage (controlled hypertension) over time
- Lower-middle income (World Bank)
- Slovakia
How they compare
Slovakia currently reports 36.1% against 13.9% in Lower-middle income (World Bank), a difference of 22.2%.
That makes Slovakia's figure about 2.6 times Lower-middle income (World Bank)'s.
Across all 30 years both countries report, Slovakia has been ahead every year.
Lower-middle income (World Bank) ranks 12th and Slovakia ranks 14th of 17 groups.
Slovakia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lower-middle income (World Bank) | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 3.1% | 9.0% | 5.9% | Slovakia |
| 2000s | 6.2% | 18.4% | 12.2% | Slovakia |
| 2010s | 11.2% | 30.9% | 19.7% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), Lower-middle income (World Bank) or Slovakia?
- Slovakia, at 36.1% against 13.9% in Lower-middle income (World Bank) as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between Lower-middle income (World Bank) and Slovakia?
- 22.2%, with Slovakia ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and Slovakia?
- 30 years are reported by both, from 1990 to 2019.
- How do Lower-middle income (World Bank) and Slovakia rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- Lower-middle income (World Bank) ranks 12th and Slovakia ranks 14th of 17 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.